TSXV - Free Realtime Quote CAD

Cannara Biotech Inc. (LOVE.V)

0.8500 +0.0200 (+2.41%)
As of 9:52 AM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Mr. Zohar Krivorot CEO & Chairman 300k -- 1977
Mr. Nicholas Sosiak C.A., CPA Chief Financial Officer 240k -- --
Mr. Avi Krivorot Chief Technology Officer 300k -- --
Mr. Anthony Manouk VP of Compliance & GM 160k -- --
Mr. Brian Sherman General Counsel & VP Legal Affairs -- -- --
Mr. David Abitbol Vice President of Marketing -- -- --
Scott Carroll Vice President of Marketing & Sales -- -- --
Ms. France Landry Vice President of Human Resources -- -- --
Ms. Julia Bouvet Chief of Staff -- -- --
Etienne Ledoux Executive Officer 300k -- --

Cannara Biotech Inc.

333 Decarie Blvd.
Suite 200
Saint-Laurent, QC H4N 3M9
Canada
514-543-4200 https://cannara.ca
Sector: 
Healthcare

Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Corporate Governance

Cannara Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 02, 2024 - May 06, 2024
Cannara Biotech Inc. Earnings Call

Related Tickers